A Hendershot, M Slabaugh,
KM Riaz, KN Moore… - Gynecologic Oncology …, 2023 - Elsevier
Mirvetuximab soravtansine (MIRV) is a first-in-class antibody-drug conjugate (ADC)
targeting folate receptor alpha (FRα) and is indicated for the treatment of adult patients with …